Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
31.
Genetics reveal why people respond differently to GLP-1 weight-loss drugs (feeds.nature.com)
32.
Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests (feeds.feedburner.com)
33.
Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That’s Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors, Phony Before-and-After Pictures, and Other Glaring Red Flags? (futurism.com)
34.
A new weight-loss pill is here, and it could reshape the GLP-1 market (feeds.feedburner.com)
35.
FDA Approves Eli Lilly’s GLP-1 Pill (wired.com)
36.
FDA Approves Eli Lilly's GLP-1 Pill (wired.com)
37.
Wall Street's rough month, Powell's inflation outlook, GLP-1 subscription and more in Morning Squawk (cnbc.com)
38.
Riding the GLP-1 boom, VITL lands $7.5M to overhaul cash-pay clinic prescribing (techcrunch.com)
39.
Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s (futurism.com)
40.
Ro CEO on the next phase of the Ozempic boom (feeds.feedburner.com)
41.
Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists (news.ycombinator.com)
42.
Heart Attack and Stroke Risk Jumps When People Stop Taking GLP-1s (news.ycombinator.com)
43.
Python Blood Could Kickstart the Next Big Thing in Weight Loss (gizmodo.com)
44.
Is It Safe to Inject Gray-Market Chinese Peptides? (futurism.com)
45.
Quitting Ozempic Could Hit Your Heart Hard, Study Finds (gizmodo.com)
46.
Your Off-Brand GLP-1 Is Dirtier Than You Think (gizmodo.com)
47.
Why smaller portions are the biggest restaurant trend right now (feeds.feedburner.com)
48.
Novo Nordisk and Hims End Their Ozempic War. Here’s What It Means for You (gizmodo.com)
Today's top topics: microsoft author bars birthdate birthdate word candy comments centers data centers adaptive
View all today's topics →